Clinical trial / 2020
Cinnamon supplementation significantly reduced migraine attack frequency, severity, duration, and inflammatory markers (IL-6 and NO) in migraine patients.
Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.
- Study type
- Randomized double-blind placebo-controlled trial
- Who was studied
- 50 patients with migraine
- What was measured
- Serum levels of IL-6, CGRP, and NO; frequency, severity, and duration of migraine attacks
THE PAPER
Effect of cinnamon on migraine attacks and inflammatory markers: A randomized double-blind placebo-controlled trial.
Zareie A, Sahebkar A, Khorvash F, Bagherniya M, Hasanzadeh A, Askari G. Phytother Res, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.